description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
GTGGACAGCCACAGCAGTTACTGCAGGTCTTACAGCAAACTCTTCCACCACCAGTGTTCCAGATGCTTCTGACTAAGCTCCCAACAATTAGTCAGAGAATTGTAAGTGCTCAGAGCTTGGCTGAAGATGATGTGGAATGAGAAACAAATGTCAACATAATAAAATCTCAGTTAAAAATATTTTAAAAATTCTTGGTAGTTGAGCAGCTCTGGGGGAATAAGGGCAAATATGCTTGTTATGAACTACACTGAAATCTACCAAAGTTAATGTTTACTTTGTGTAGATCCATTTGTCTATTTTATTTATTTTTCCCAGTGAAAAGTGTATTTTGATAGAGAACTTTTCATTCTATAAATACACTATGAGTTACTAAAATATCATGGATTTTGTTTATTCCTGAAACA
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Shrijal S Shah et al.
Journal of the American Society of Nephrology : JASN, 30(12), 2355-2368 (2019-09-29)
Genetic Variants in Apolipoprotein L1 (APOL1) are associated with large increases in CKD rates among African Americans. Experiments in cell and mouse models suggest that these risk-related polymorphisms are toxic gain-of-function variants that cause kidney dysfunction, following a recessive mode
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EHU046171-20UG | 04061831342741 |
| EHU046171-50UG | 04061828319541 |